General American Investors’s Aratana Therapeutics, Inc. PETX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-1,415,824
Closed -$7.31M 72
2019
Q2
$7.31M Sell
1,415,824
-1,102
-0.1% -$4.95K 0.69% 48
2019
Q1
$5.1M Sell
1,416,926
-182,439
-11% -$791K 0.51% 54
2018
Q4
$9.8M Sell
1,599,365
-274,999
-15% -$1.68M 1.03% 42
2018
Q3
$10.9M Buy
1,874,364
+256,441
+16% +$1.28M 0.94% 48
2018
Q2
$6.88M Hold
1,617,923
0.63% 53
2018
Q1
$7.13M Buy
1,617,923
+500,000
+45% +$2.23M 0.68% 49
2017
Q4
$5.88M Buy
1,117,923
+250,323
+29% +$1.53M 0.57% 50
2017
Q3
$5.32M Buy
867,600
+248,940
+40% +$1.58M 0.5% 53
2017
Q2
$4.47M Buy
618,660
+94,201
+18% +$579K 0.45% 51
2017
Q1
$2.78M Buy
524,459
+38,991
+8% +$263K 0.27% 54
2016
Q4
$3.49M Buy
485,468
+73,367
+18% +$593K 0.35% 55
2016
Q3
$3.86M Hold
412,101
0.39% 54
2016
Q2
$2.6M Buy
+412,101
New +$2.65M 0.27% 52

Other funds holding PETX